Remogliflozin is a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor used to manage type 2 diabetes. It works by preventing the reabsorption of glucose in the kidneys, promoting the excretion of glucose in the urine. Remogliflozin helps lower blood sugar levels and can contribute to weight loss and improved cardiovascular health.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Remogliflozin and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Remogliflozin impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Remogliflozin-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
